DSY.PA - Dassault Systemes SE

Paris - Paris Delayed Price. Currency in EUR
148.90
+0.95 (+0.64%)
As of 12:32PM CEST. Market open.
Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
    9M+
Previous Close147.95
Open149.80
Bid0.00 x 0
Ask0.00 x 0
Day's Range147.30 - 149.80
52 Week Range105.00 - 164.15
Volume110,796
Avg. Volume468,253
Market Cap38.562B
Beta (5Y Monthly)0.65
PE Ratio (TTM)69.22
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield0.70 (0.47%)
Ex-Dividend DateMay 28, 2020
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Thomson Reuters StreetEvents

      Edited Transcript of DSY.PA earnings conference call or presentation 23-Apr-20 1:00pm GMT

      Q1 2020 Dassault Systemes SE Earnings Call - Afternoon Session

    • Shareholders Should Look Hard At Dassault Systèmes SE’s (EPA:DSY) 7.2%Return On Capital
      Simply Wall St.

      Shareholders Should Look Hard At Dassault Systèmes SE’s (EPA:DSY) 7.2%Return On Capital

      Today we are going to look at Dassault Systèmes SE (EPA:DSY) to see whether it might be an attractive investment...

    • Ansys: A Cost-Saver and Growth Driver for Innovators
      GuruFocus.com

      Ansys: A Cost-Saver and Growth Driver for Innovators

      A broad moat, multi-cylinder growth engine and recurring revenue model shed light on long-term shareholder value of the software business Continue reading...

    • Is Dassault Systèmes (EPA:DSY) A Risky Investment?
      Simply Wall St.

      Is Dassault Systèmes (EPA:DSY) A Risky Investment?

      Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

    • What Does Dassault Systèmes SE's (EPA:DSY) P/E Ratio Tell You?
      Simply Wall St.

      What Does Dassault Systèmes SE's (EPA:DSY) P/E Ratio Tell You?

      The goal of this article is to teach you how to use price to earnings ratios (P/E ratios). We'll show how you can use...

    • Simply Wall St.

      Does Dassault Systèmes SE's (EPA:DSY) CEO Pay Matter?

      Bernard Charlès became the CEO of Dassault Systèmes SE (EPA:DSY) in 2002. First, this article will compare CEO...

    • Thomson Reuters StreetEvents

      Edited Transcript of DSY.PA earnings conference call or presentation 24-Oct-19 1:00pm GMT

      Q3 2019 Dassault Systemes SE Earnings Call

    • Is Dassault Systèmes (EPA:DSY) Using Too Much Debt?
      Simply Wall St.

      Is Dassault Systèmes (EPA:DSY) Using Too Much Debt?

      Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...

    • France recruits Dassault Systemes, OVH for alternative to U.S. cloud firms
      Reuters

      France recruits Dassault Systemes, OVH for alternative to U.S. cloud firms

      France has enlisted tech companies Dassault Systemes and OVH to come up with plans to break the dominance of U.S. companies in cloud computing, its finance minister said on Thursday. Paris is eager to build up a capacity to store sensitive data in France amid concerns the U.S. government can obtain data kept on the servers of U.S. companies such as Amazon and Microsoft.

    • Should You Think About Buying Dassault Systèmes SE (EPA:DSY) Now?
      Simply Wall St.

      Should You Think About Buying Dassault Systèmes SE (EPA:DSY) Now?

      Dassault Systèmes SE (EPA:DSY) received a lot of attention from a substantial price movement on the ENXTPA over the...

    • Thomson Reuters StreetEvents

      Edited Transcript of DSY.PA earnings conference call or presentation 24-Jul-19 8:00am GMT

      Half Year 2019 Dassault Systemes SE Earnings Presentation

    • Does Dassault Systèmes SE's (EPA:DSY) CEO Salary Compare Well With Others?
      Simply Wall St.

      Does Dassault Systèmes SE's (EPA:DSY) CEO Salary Compare Well With Others?

      In 2002 Bernard Charlès was appointed CEO of Dassault Systèmes SE (EPA:DSY). This analysis aims first to contrast CEO...

    • Dassault to Buy Medidata in $5.7 Billion Shift to Health
      Bloomberg

      Dassault to Buy Medidata in $5.7 Billion Shift to Health

      (Bloomberg) -- French technology company Dassault Systemes SE agreed to buy Medidata Solutions Inc., a software firm that analyzes clinical trials, for $5.7 billion to bolster its offerings to the pharmaceutical industry.The record deal will allow Dassault to offer drugmakers a complete set of services and ride a shift toward personalized medicine, in which research and tools are tailored to individual patient profiles, generating the need to analyze vast amounts of data.Health is becoming a crucial market for Dassault, which also creates 3D design software, said Pascal Daloz, the company’s chief financial officer. Medidata offers clients wearable sensors that help track patients’ health in real life and biomarker analysis to select which ones may best respond to drugs. It estimates that 13 of the top 15 medicines sold last year relied on its technology.“This is by far the largest acquisition we’ve ever made,” Daloz said on a conference call, highlighting Dassault’s interest in the health market.Drugmakers’ CostsThe all-cash transaction values Medidata at $92.25 a share -- 17% more than Medidata’s closing price on April 18, the last trading day before Bloomberg reported Dassault’s interest in the New York-based company. Medidata shares were down 3.5% to $91.45 at 9:59 a.m. in New York. Dassault fell 1.5% to 134.45 euros in Paris.The deal is expected to close in the final quarter of 2019 and start boosting earnings as early as 2020, the companies said in a statement.Drugmakers faced with rising development costs are outsourcing many parts of their research and development efforts, using specialized providers of services and technology.Medidata counts most of the biggest drug companies in the world as customers, according to supply-chain data compiled by Bloomberg. It provides a cloud-based subscription service that helps medical device, diagnostic and pharmaceutical companies manage and analyze clinical trials. Its revenue more than doubled from 2013 to 2018, when it brought in $635.7 million.Dassault, with a market value of 36 billion euros ($41 billion), offers software and services for industries ranging from aerospace and defense to consumer goods. The life sciences business counts many major pharma companies among its clients.The planned acquisition, endorsed by both boards, marks the first time the French company has resorted to external funding, according to Daloz. Dassault will finance the takeover with a 1 billion-euro loan, a 3 billion-euro bridge-to-loan facility and available cash.(Updates with Dassault shares in sixth paragraph.)\--With assistance from Liana Baker, Geraldine Amiel and Marie Mawad.To contact the reporters on this story: Ed Hammond in New York at ehammond12@bloomberg.net;Ruth David in London at rdavid9@bloomberg.net;Manuel Baigorri in Hong Kong at mbaigorri@bloomberg.netTo contact the editors responsible for this story: Elizabeth Fournier at efournier5@bloomberg.net, ;Giles Turner at gturner35@bloomberg.net, Jeff Sutherland, Thomas MulierFor more articles like this, please visit us at bloomberg.com©2019 Bloomberg L.P.

    • Dassault Systemes targets life sciences with $5.8 billion Medidata deal
      Reuters

      Dassault Systemes targets life sciences with $5.8 billion Medidata deal

      France's Dassault Systemes moved to build up its life sciences presence with a $5.8 billion cash deal to buy Medidata Solutions, a U.S. firm focused on clinical trials. Dassault Systemes has been doing deals to diversify its technology and software businesses further and its agreed acquisition of Medidata, its largest, follows its purchases of companies including Trace Software and Argosim. Medidata has a market capitalisation of around $5.9 billion, Refinitiv Eikon data shows, while Dassault has a stock market value of around 36 billion euros ($41 billion).

    • Reuters

      France's Dassault nears deal to buy healthcare software maker Medidata: CNBC

      Shares of Medidata were up 5.5% at $100 in after-hours trading. Cloud-based Medidata's software is used to help clinics manage back office operations and data, besides providing analytics tools, the report said. The Medidata deal will be Dassault's third acquisition this year.